MELVILLE, N.Y., March 15, 2016 -- The Board of Directors of Park Electrochemical Corp. (NYSE:PKE) declared a regular quarterly dividend of $0.10 per share payable May 4, 2016 to shareholders of record at the close of business on April 4, 2016.
Park has paid 30 consecutive years of uninterrupted regular, quarterly cash dividends without ever skipping a dividend payment or reducing the amount of the dividend.
Park Electrochemical Corp. is a global advanced materials company which develops and manufactures high-technology digital and RF/microwave printed circuit materials principally for the telecommunications and internet infrastructure and high-end computing markets and advanced composite materials, parts and assemblies and low-volume tooling for the aerospace markets. Park’s core capabilities are in the areas of polymer chemistry formulation and coating technology. The Company’s manufacturing facilities are located in Singapore, France, Kansas, Arizona and California. The Company also maintains R & D facilities in Arizona, Kansas and Singapore.
Additional corporation information is available on the Company’s web site at www.parkelectro.com.
Contact: Martina Bar Kochva 48 South Service Road Melville, NY 11747 (631) 465-3600


Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 



